. . . . . " "@en . "Brompheniramine works by acting as an antagonist of the H1 histamine receptors. It also functions as a moderately effective anticholingeric agent, likely an antimuscarinic agent similar to other common antihistamines such as diphenhydramine. Its effects on the cholinergic system may include side-effects such as drowsiness, sedation, dry mouth, dry throat, blurred vision, and increased heart rate."@en . . . . "Bromfeniramina"@en . . . . . "[3-(4-Bromo-phenyl)-3-pyridin-2-yl-propyl]-dimethyl-amine"@en . "Brompheniramine"@en . . . . "1-(P-Bromophenyl)-1-(2-pyridyl)-3-dimethylaminopropane"@en . . . . . . "For the treatment of the symptoms of the common cold and allergic rhinitis, such as runny nose, itchy eyes, watery eyes, and sneezing."@en . . . . . . . . . . . . . . . . . . "Antihistamines are well absorbed from the gastrointestinal tract after oral administration."@en . . "3-(4-Bromophenyl)-N,N-dimethyl-3-(2-pyridinyl)-1-propanamine"@en . . . . . . . . . . . . . " "@en . . . . . . . . "approved"@en . . . . . . . . . . . "BPN"@en . . . . "Bromph\u00E9niramine"@en . . . . . . . . . . . . . . . . "Oral, rat: LD₅₀ = 318 mg/kg. Signs of overdose include fast or irregular heartbeat, mental or mood changes, tightness in the chest, and unusual tiredness or weakness."@en . . . . . "Brompheniraminum"@en . . . . "2-(P-Bromo-alpha-(2-dimethylaminoethyl)benzyl)pyridine"@en . "Humans and other mammals"@en . . . . . . . . . . . . . . . . . . "86-22-6"@en . . . . . . . . . . . . . . . "Avoid alcohol."@en . . "Sperber, N., Papa, D. and Schwenk, E.; US. Patent 2,567,245; September 11, 1951; assigned to Schering Corporation. Sperber, N., Papa, D. and Schwenk, E.; U.S. Patent 2,676,964: April 27,1954; assigned to Schering Corporation."@en . . "Brompheniramin"@en . . . . "Histamine H1 antagonist used in treatment of allergies, rhinitis, and urticaria. [PubChem]"@en . . "Take with food."@en . . . . "3-(P-Bromophenyl)-3-(2-pyridyl)-N,N-dimethylpropylamine"@en . . .